Removing one type of T cell from donor blood used for stem cell grafts could greatly reduce a serious complication called graft-versus-host disease in patients with leukemia, according to a new study.
Click here for original story, New graft strategy may improve outcomes for blood stem cell recipients
Source: ScienceDaily